Brain serotonin transporter in human methamphetamine users

Psychopharmacology

Volumn 202, Issue 4, 2009, Pages 649-661

  Kish, Stephen J ^a   Fitzmaurice, Paul S ^b   Boileau, Isabelle ^a   Schmunk, Gregory A ^c   Ang, Lee Cyn ^d   Furukawa, Yoshiaki ^a   Chang, Li Jan ^a   Wickham, Dennis J ^e   Sherwin, Allan ^f   Tong, Junchao ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b MT ALBERT RESEARCH CENTRE   (New Zealand)

^c Office of the Polk County Medical Examiner   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e Clark Co Off of the Med Examiner   (United States)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Methamphetamine; Orbitofrontal cortex; Post mortem human brain; Serotonin; Serotonin transporter; Tryptophan hydroxylase

Indexed keywords

METHAMPHETAMINE; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; AUTOPSY; CAUDATE NUCLEUS; DOPAMINERGIC NERVE CELL; DRUG ABUSE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; NEUROCHEMISTRY; OCCIPITAL CORTEX; ORBITAL CORTEX; PRIORITY JOURNAL; PUTAMEN; TEMPORAL CORTEX; THALAMUS;

ADULT; AMPHETAMINE-RELATED DISORDERS; AUTOPSY; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HAIR; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; METHAMPHETAMINE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE; YOUNG ADULT;

EID: 59849103809     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-008-1346-x     Document Type: Article

References (79)

1. RL Albin RA Koeppe NI Bohnen K Wernette MA Kilbourn KA Frey 2008 Spared caudal brainstem SERT binding in early Parkinson's disease J Cereb Blood Flow Metab 28 441 444
2. K Ando CE Johanson LS Seiden CR Schuster 1985 Sensitivity changes to dopaminergic agents in fine motor control of rhesus monkeys after repeated methamphetamine administration Pharmacol Biochem Behav 22 737 743
3. KJ Axt ME Molliver 1991 Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain Synapse 9 302 313
4. Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ (2008) Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: is VMAT2 a stable dopamine neuron biomarker? J Neurosci 28:9850-9856
5. 11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling? J Psychopharmacol 21 628 634
6. YH Chou WS Huang TP Su RB Lu FJ Wan YK Fu 2007 Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study Eur Neuropsychopharmacol 17 46 52
7. G Di Chiara A Imperato 1988 Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc Natl Acad Sci USA 85 5274 5278
8. KD Ersche PC Fletcher SJ Lewis L Clark G Stocks-Gee M London JB Deakin TW Robbins BJ Sahakian 2005 Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals Psychopharmacology (Berl) 180 612 623
9. KT Finnegan G Ricaurte LS Seiden CR Schuster 1982 Altered sensitivity to d-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine Psychopharmacology (Berl) 77 43 52
10. PS Fitzmaurice J Tong M Yazdanpanah PP Liu KS Kalasinsky SJ Kish 2006 Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine J Pharmacol Exp Ther 319 703 709
11. PJ Fletcher KM Korth JW Chambers 1999 Depletion of brain serotonin following intra-raphe injections of 5,7-dihydroxytryptamine does not alter d-amphetamine self-administration across different schedule and access conditions Psychopharmacology (Berl) 146 185 193
12. 11C-McN 5652 in healthy humans J Nucl Med 45 682 694
13. 11C]McN 5652 Am J Psychiatry 162 915 923
14. M Guttman I Boileau J Warsh JA Saint-Cyr N Ginovart T McCluskey S Houle A Wilson E Mundo P Rusjan J Meyer SJ Kish 2007 Brain serotonin transporter binding in non-depressed patients with Parkinson's disease Eur J Neurol 14 523 528
15. HM Haughey AE Fleckenstein RR Metzger GR Hanson 2000 The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia J Neurochem 75 1608 1617
16. GA Higgins PJ Fletcher 2003 Serotonin and drug reward: focus on 5-HT2C receptors Eur J Pharmacol 480 151 162
17. H Higuchi T Matsuo K Shimamoto 1962 Effects of methamphetamine and cocaine on the depletion of catecholamine of the brain, heart and adrenal gland in rabbit by reserpine Jpn J Pharmacol 12 48 56
18. CE Johanson KA Frey LH Lundahl P Keenan N Lockhart J Roll GP Galloway RA Koeppe MR Kilbourn T Robbins CR Schuster 2006 Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers Psychopharmacology (Berl) 185 327 338
19. M Johnson DM Stone GR Hanson JW Gibb 1987 Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system Eur J Pharmacol 135 231 234
20. KS Kalasinsky TZ Bosy GA Schmunk G Reiber RM Anthony Y Furukawa M Guttman SJ Kish 2001 Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users Forensic Sci Int 116 163 169
21. L Kerenyi GA Ricaurte DJ Schretlen U McCann J Varga WB Mathews HT Ravert RF Dannals J Hilton DF Wong Z Szabo 2003 Positron emission tomography of striatal serotonin transporters in Parkinson disease Arch Neurol 60 1223 1229
22. SJ Kish 2002 How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacol Biochem Behav 71 845 855
23. SJ Kish 2003 Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? Adv Neurol 91 39 49
24. SJ Kish 2008 Pharmacologic mechanisms of crystal meth Can Med Assoc J 178 1679 1682
25. SJ Kish A Olivier F Dubeau Y Robitaille AL Sherwin 1988 Increased activity of choline acetyltransferase and acetylcholinesterase in actively epileptic human cerebral cortex Epilepsy Res 2 227 231
26. SJ Kish K Shannak O Hornykiewicz 1988 Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications N Engl J Med 318 876 880
27. SJ Kish Y Furukawa L Ang SP Vorce KS Kalasinsky 2000 Striatal serotonin is depleted in brain of a human MDMA (ecstasy) user Neurology 55 294 296
28. SJ Kish Y Furukawa LJ Chang J Tong N Ginovart A Wilson S Houle JH Meyer 2005 Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nucl Med Biol 32 123 128
29. SJ Kish T McCluskey J Meyer AA Wilson S Houle 2007 Brain serotonin transporter concentration is decreased in chronic users of the drug ecstasy: a preliminary report Ther Drug Monitor 29 495
30. SJ Kish J Tong O Hornykiewicz A Rajput LJ Chang M Guttman Y Furukawa 2008 Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease Brain 131 120 131
31. Kish SJ, Fitzmaurice PS, Chang LJ, Furukawa Y, Tong J (2008b) Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study. J Psychopharmacology (in press)
32. O Kitamura I Tokunaga T Gotohda S Kubo 2007 Immunohistochemical investigation of dopaminergic terminal markers and caspase-3 activation in the striatum of human methamphetamine users Int J Legal Med 121 163 168
33. R Laverty DF Sharman 1965 Modification by drugs of the metabolism of 3,4-dihydroxyphenylethylamine, noradremaline and 5-hydroxytryptamine in the brain Br J Pharmacol Chemother 24 759 772
34. 11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters Eur Neuropsychopharmacol 16 220 223
35. DC Mash JK Staley S Izenwasser M Basile AJ Ruttenber 2000 Serotonin transporters upregulate with chronic cocaine use J Chem Neuroanat 20 271 280
36. 11C]WIN-35,428 J Neurosci 18 8417 8422
37. UD McCann Z Szabo U Scheffel RF Dannals GA Ricaurte 1998 Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings Lancet 352 1433 1437
38. 11C]DASB Neuropsychopharmacology 30 1741 1750
39. UD McCann H Kuwabara A Kumar M Palermo R Abbey J Brasic W Ye M Alexander RF Dannals DF Wong GA Ricaurte 2008 Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users Synapse 62 91 100
40. UD McCann Z Szabo M Vranesic M Palermo WB Mathews HT Ravert RF Dannals GA Ricaurte 2008 Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance Psychopharmacology (Berl) 200 439 450
41. JR McLean M McCartney 1961 Effect of d-amphetamine on rat brain noradrenaline and serotonin Proc Soc Exp Biol Med 107 77 79
42. WP Melega MJ Raleigh DB Stout G Lacan SC Huang ME Phelps 1997 Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey Brain Res 766 113 120
43. WP Melega MJ Jorgensen G Laćan BM Way J Pham G Morton AK Cho LA Fairbanks 2008 Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles Neuropsychopharmacology 33 1441 1452
44. S Montañez WA Owens GG Gould DL Murphy LC Daws 2003 Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice J Neurochem 86 210 219
45. A Moszczynska P Fitzmaurice L Ang KS Kalasinsky GA Schmunk FJ Peretti SS Aiken DJ Wickham SJ Kish 2004 Why is parkinsonism not a feature of human methamphetamine users? Brain 127 363 370
46. CP Müller RJ Carey JP Huston MA De Souza Silva 2007 Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors Prog Neurobiol 81 133 178
47. E Mundo M Walker T Cate F Macciardi JL Kennedy 2001 The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings Arch Gen Psychiatry 58 539 544
48. JP O'Callaghan DB Miller 1994 Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse J Pharmacol Exp Ther 270 741 751
49. MK Paasonen M Vogt 1956 The effect of drugs on the amounts of substance P and 5-hydroxytryptamine in mammalian brain J Physiol 131 617 626
50. MP Paulus NE Hozack BE Zauscher L Frank GG Brown DL Braff MA Schuckit 2002 Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects Neuropsychopharmacology 26 53 63
51. MP Paulus N Hozack L Frank GG Brown MA Schuckit 2003 Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation Biol Psychiatry 53 65 74
52. KL Preston GC Wagner CR Schuster LS Seiden 1985 Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain Brain Res 338 243 248
53. 123I]beta-CIT SPECT study-preliminary report Psychopharmacology (Berl) 159 335 340
54. GA Ricaurte UD McCann 2001 Experimental studies on 3,4- methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons Neurotox Res 3 85 99
55. GA Ricaurte CR Schuster LS Seiden 1980 Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study Brain Res 193 153 163
56. GA Ricaurte RW Guillery LS Seiden CR Schuster RY Moore 1982 Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain Brain Res 235 93 103
57. GA Ricaurte J Yuan G Hatzidimitriou BJ Cord UD McCann 2002 Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy"). Science 297:2260-2263. Retraction in: Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD (2003) Science 301 1479
58. Riley HA (1943) An atlas of the basal ganglia, brain stem and spinal cord. Williams & Wilkins, Baltimore, MD
59. RD Rogers BJ Everitt A Baldacchino AJ Blackshaw R Swainson K Wynne NB Baker J Hunter T Carthy E Booker M London JF Deakin BJ Sahakian TW Robbins 1999 Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms Neuropsychopharmacology 20 322 339
60. JD Salamone M Correa A Farrar SM Mingote 2007 Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits Psychopharmacology (Berl) 191 461 482
61. CJ Schmidt PK Sonsalla GR Hanson MA Peat JW Gibb 1985 Methamphetamine-induced depression of monoamine synthesis in the rat: development of tolerance J Neurochem 44 852 855
62. JC Scott SP Woods GE Matt RA Meyer RK Heaton JH Atkinson I Grant 2007 Neurocognitive effects of methamphetamine: a critical review and meta-analysis Neuropsychol Rev 17 275 297
63. LS Seiden MW Fischman CR Schuster 1976 Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys Drug Alcohol Depend 1 215 219
64. Y Sekine M Iyo Y Ouchi T Matsunaga H Tsukada H Okada E Yoshikawa M Futatsubashi N Takei N Mori 2001 Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET Am J Psychiatry 158 1206 1214
65. Y Sekine Y Ouchi N Takei E Yoshikawa K Nakamura M Futatsubashi H Okada Y Minabe K Suzuki Y Iwata KJ Tsuchiya H Tsukada M Iyo N Mori 2006 Brain serotonin transporter density and aggression in abstinent methamphetamine abusers Arch Gen Psychiatry 63 90 100
66. S Shoptaw A Huber J Peck X Yang J Liu J Dang J Roll B Shapiro E Rotheram-Fuller W Ling 2006 Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence Drug Alcohol Depend 85 12 8
67. 11)C-DASB as serotonin transporter radioligands under various experimental conditions J Nucl Med 43 678 692
68. J Tong BM Ross GA Schmunk FJ Peretti KS Kalasinsky Y Furukawa LC Ang SS Aiken DJ Wickham SJ Kish 2003 Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users Am J Psychiatry 160 896 903
69. J Tong O Hornykiewicz Y Furukawa SJ Kish 2007 Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens J Neurochem 102 1691 1702
70. 11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations J Neurosci 18 419 427
71. BA Völlm IE de Araujo PJ Cowen ET Rolls ML Kringelbach KA Smith P Jezzard RJ Heal PM Matthews 2004 Methamphetamine activates reward circuitry in drug naïve human subjects Neuropsychopharmacology 29 1715 1722
72. ND Volkow L Chang GJ Wang JS Fowler M Leonido-Yee D Franceschi MJ Sedler SJ Gatley R Hitzemann YS Ding J Logan C Wong EN Miller 2001 Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am J Psychiatry 158 377 382
73. ND Volkow L Chang GJ Wang JS Fowler D Franceschi M Sedler SJ Gatley E Miller R Hitzemann YS Ding J Logan 2001 Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence J Neurosci 21 9414 9418
74. 2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex Am J Psychiatry 158 2015 2021
75. 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration J Neurosci 14 2966 2979
76. JM Wilson KS Kalasinsky AI Levey C Bergeron G Reiber RM Anthony GA Schmunk K Shannak JW Haycock SJ Kish 1996 Striatal dopamine nerve terminal markers in human, chronic methamphetamine users Nat Med 2 699 703
77. WL Woolverton GA Ricaurte LS Forno LS Seiden 1989 Long-term effects of chronic methamphetamine administration in rhesus monkeys Brain Res 486 73 78
78. J Yuan G Hatzidimitriou P Suthar M Mueller U McCann G Ricaurte 2006 Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys J Pharmacol Exp Ther 316 1210 1218
79. JE Zweben JB Cohen D Christian GP Galloway M Salinardi D Parent M Iguchi for the Methamphetamine Treatment Project 2004 Psychiatric symptoms in methamphetamine users Am J Addict 13 181 190